CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers

Transcriptional factor 4 (TCF4), encoding a basic helix-loop-helix transcriptional factor, has recently been demonstrated as a causative gene for Pitt-Hopkins syndrome, a neurodevelopmental disease. Examination of gastric cancers using the restriction landmark genomic scanning technique revealed methylation at a NotI enzyme site in TCF4 intron 8 and further identified CpG dinucleotide hypermethylation in TCF4 exon 1, strongly associated with gene silencing in gastric cancer cell lines. Treatment with 5-aza-2′-deoxycytidine and/or trichostatin A restored TCF4 expression in TCF4-silenced gastric cancer cell lines. Real-time reverse transcription–polymerase chain reaction analysis of 77 paired primary gastric tumor samples revealed that 38% of analyzed tumors had a >2-fold decrease in TCF4 expression compared with adjacent normal-appearing tissue, and the decrease significantly correlated with increased CpG methylation in TCF4 exon 1. Clinicopathologic data showed that decreased TCF4 expression occurred significantly more frequently in intestinal-type (22/37, 59%) than in diffuse-type (7/37, 19%) gastric cancers (P = 0.0004) and likewise more frequently in early (12/18, 67%) than in advanced (17/59, 29%) gastric cancers (P = 0.004). CpG methylation markedly increased with patient age among normal-appearing tissues, suggesting that CpG methylation in gastric mucosa may be one of the earliest events in carcinogenesis of intestinal-type gastric cancers. Furthermore, ectopic expression of TCF4 decreased cell growth in a gastric cancer cell line, and the knock down of TCF4 using small interfering RNA increased cell migration. Based on these results, we propose that the observed frequent epigenetic-mediated TCF4 silencing plays a role in tumor formation and progression.

[1]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[2]  Valérie Ledent,et al.  Phylogenetic analysis of the human basic helix-loop-helix proteins , 2002, Genome Biology.

[3]  T. Akiyama,et al.  Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein , 2000, Genes & Development.

[4]  Juliane Hoyer,et al.  Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). , 2007, American journal of human genetics.

[5]  L. Valanne,et al.  Pitt–Hopkins syndrome in two patients and further definition of the phenotype , 2006, Clinical dysmorphology.

[6]  W. Grady.  Epigenetic events in the colorectum and in colon cancer. , 2005, Biochemical Society transactions.

[7]  X. Sun,et al.  A novel enhancer, the pro-B enhancer, regulates Id1 gene expression in progenitor B cells , 1995, Molecular and cellular biology.

[8]  Elaine R. Mardis,et al.  In Genome analysis: A laboratory manual , 1997 .

[9]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[10]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[11]  C. R. Leemans,et al.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. , 2003, Cancer research.

[12]  Y. Yuasa,et al.  Alterations and hypermethylation of the p14ARF gene in gastric cancer , 2000, International journal of cancer.

[13]  C. Murre,et al.  Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms , 2000, Molecular and Cellular Biology.

[14]  IT KOREA 미래전략 , 2009 .

[15]  David Baltimore,et al.  Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo , 1991, Cell.

[16]  Jeong-Hwan Kim,et al.  The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. , 2006, Biochemical and biophysical research communications.

[17]  H. Axelson,et al.  HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. , 2000, Biochemical and biophysical research communications.

[18]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[19]  A. Rashid,et al.  Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer , 2003, Gut.

[20]  Jun Yu,et al.  Concurrent hypermethylation of multiple tumor‐related genes in gastric carcinoma and adjacent normal tissues , 2001, Cancer.

[21]  Kathleen R. Cho,et al.  ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. , 2002, Cancer cell.

[22]  U. Schüller,et al.  Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas , 2005, Clinical Cancer Research.

[23]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[24]  A. Hoischen,et al.  Severe mental retardation with breathing abnormalities (Pitt-Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. , 2007, Human molecular genetics.

[25]  G. Kang,et al.  Correlation of p16 Hypermethylation with p16 Protein Loss in Sporadic Gastric Carcinomas , 2000, Laboratory Investigation.

[26]  Y. Hayashizaki,et al.  A genomic scanning method for higher organisms using restriction sites as landmarks. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J R Matthews,et al.  Structure and function of helix-loop-helix proteins. , 1994, Biochimica et biophysica acta.

[28]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[29]  H. Yokozaki,et al.  Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma , 2001, International journal of cancer.

[30]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[31]  Kim Jeong-Hwan,et al.  Cloning of Notl-linked DNA Detected by Restriction Landmark Genomic Scanning of Human Genome , 2006 .

[32]  S. Baylin,et al.  DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.

[33]  G. Church,et al.  Cell-type-specific contacts to immunoglobulin enhancers in nuclei , 1985, Nature.

[34]  L. Lania,et al.  Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. , 2000, Cancer research.

[35]  W. Atchley,et al.  A natural classification of the basic helix-loop-helix class of transcription factors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. H. Kim,et al.  CpG island methylation in premalignant stages of gastric carcinoma. , 2001, Cancer research.

[37]  Y. Jan,et al.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.

[38]  J. Ajani,et al.  Molecular basis of gastric cancer development and progression , 2004, Gastric Cancer.

[39]  D. Pitt,et al.  A Syndrome of Mental Retardation, Wide Mouth and Intermittent Overbreathing , 1978, Australian paediatric journal.

[40]  Richard W. Carthew,et al.  Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway , 2003, Nature.

[41]  C. Murre,et al.  E protein function in lymphocyte development. , 2002, Annual review of immunology.

[42]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[43]  Nathalie Boddaert,et al.  Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. , 2007, American journal of human genetics.

[44]  G. Beck,et al.  Gene array analysis of osteoblast differentiation. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[45]  Eric D. Green,et al.  Genome analysis : a laboratory manual , 1997 .

[46]  J. Willis,et al.  Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer , 2000, Nature Genetics.

[47]  M. Tsai,et al.  Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. , 1995, Genes & development.

[48]  R. Moon,et al.  Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway. , 2003, Nature.

[49]  H. Lee,et al.  Gastric cancer in Korea , 2002, Gastric Cancer.

[50]  Susan Jones,et al.  An overview of the basic helix-loop-helix proteins , 2004, Genome Biology.

[51]  T. Akiyama,et al.  Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. , 2000, Genes & development.

[52]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.